April 23, 2008 - Sentry Data Systems Inc. launched the DRA Tool, a reporting and claims editing module that supports the additional reporting requirements of Section 6002 of the Federal Deficit Reduction Act (DRA).

The DRA Tool is feature of the company’s Sentinel RCM pharmacy revenue cycle management product.

The Federal Deficit Reduction Act (DRA), Section 6002, requires Medicaid participating ambulatory care providers to report the National Drug Code (NDC) when billing for physician-administered medications on Medicaid claims. NDC numbers uniquely identify a pharmaceutical’s vendor, product and trade package size and are maintained by the FDA. The previously unreported NDC is now required on claims submitted to Medicaid in addition to the currently required CPT/HCPCs codes and units.

Sentry's DRA Tool automatically matches the correct 11 digit NDCs with appropriate outpatient procedure codes to allow for uninterrupted claims payment by a state’s Medicaid program. Tracking the 11 Digit NDC provides a new mechanism for individual states to maximize their Medicaid rebates from manufacturers and is financially critical for states and responsible entities, said Sentry.

“Sentinel RCM’s DRA Tool provides hospitals with immediate billing compliance by either electronically editing claims as they are submitted and by providing reports that comply with each state's individual requirements,” said Travis Leonardi RPh., C.P. president and founder of Sentry Data Systems.
Existing Sentinel RCM customers need only contact Sentry for activation.
For more information: www.sentryds.com


Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now